Tenet Healthcare (THC) Misses Q2 EPS by 14c, Offers FY16 & Q3 Guidance
Get Alerts THC Hot Sheet
EPS Growth %: 0.0%
Financial Fact:
Continuing operations: -0.09
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Tenet Healthcare (NYSE: THC) reported Q2 EPS of $0.38, $0.14 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $4.87 billion versus the consensus estimate of $4.83 billion.
GUIDANCE:
Tenet Healthcare sees FY2016 EPS of $1.32-$1.67, versus the consensus of $1.93. Tenet Healthcare sees FY2016 revenue of $19.5-19.8 billion, versus the consensus of $19.4 billion.
Tenet Healthcare sees Q3 2016 EPS of $0.10-$0.25, may not compare to consensus of $0.43. Tenet Healthcare sees Q3 2016 revenue of $4.75-4.85 billion, versus the consensus of $4.7 billion.
For earnings history and earnings-related data on Tenet Healthcare (THC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
- JetBlue Airways (JBLU) stock dips as revenue declines
- Pentair (PNR) Tops Q1 EPS by 4c, Misses on Revenue; Offers FY24 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!